Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.35 |
| ▸ | CCKAR | P32238 | 9/20 | 0.34 |
| ▸ | CCKBR | P32239 | 9/20 | 0.34 |
| ▸ | ALB | P02768 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20567326 | 1.00 | GLP1R (0.45) | GLP1RFOLH1CCKARCCKBRALB | |
| SCHEMBL16478843 | 0.94 | GLP1R (0.45) | GLP1RFOLH1CCKARCCKBRALB | |
| SCHEMBL19271209 | 0.94 | GLP1R (0.45) | GLP1RFOLH1CCKARCCKBRALB | |
| SCHEMBL15849999 | 0.94 | GLP1R (0.45) | GLP1RFOLH1CCKARCCKBRALB | |
| SCHEMBL16809355 | 0.92 | GLP1R (0.50) | GLP1RFOLH1ALB | |
| SCHEMBL24734313 | 0.90 | GLP1R (0.51) | GLP1RCCKARCCKBR | |
| SCHEMBL16309301 | 0.90 | GLP1R (0.49) | GLP1RFOLH1CCKARCCKBR | |
| SCHEMBL27122639 | 0.89 | CA12 (0.31) | GLP1R | |
| SCHEMBL12981346 | 0.89 | GLP1R (0.49) | GLP1RFOLH1CCKARCCKBR | |
| SCHEMBL21242921 | 0.89 | GLP1R (0.48) | GLP1RFOLH1CCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364248-A1 | MIC-1 COMPOUNDS AND USES THEREOF | NOVO NORDISK AS (DK) | 2023-11-16 | — | — | US | disclosed |
| US-20230364248-A1 | MIC-1 COMPOUNDS AND USES THEREOF | NOVO NORDISK AS (DK) | 2023-11-16 | — | — | US | disclosed |
| EP-3630805-A1 | MIC-1 COMPOUNDS AND USES THEREOF | Novo Nordisk A/S (DK) | 2020-04-08 | — | — | EP | disclosed |
| US-20200079829-A1 | MIC-1 COMPOUNDS AND USES THEREOF | NOVO NORDISK A/S (DK) | 2020-03-12 | — | — | US | disclosed |
| US-10398782-B2 | MIC-1 compounds and uses thereof | NOVO NORDISK A/S (DK) | 2019-09-03 | — | — | US | disclosed |
| US-10398782-B2 | MIC-1 compounds and uses thereof | NOVO NORDISK A/S (DK) | 2019-09-03 | — | — | US | disclosed |
| US-20180339057-A1 | MIC-1 Compounds and Uses Thereof | NOVO NORDISK A/S (DK) | 2018-11-29 | — | — | US | disclosed |
| WO-2018215525-A1 | MIC-1 COMPOUNDS AND USES THEREOF | NOVO NORDISK A/S (DK) | 2018-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079829-A1 | MIC-1 COMPOUNDS AND USES THEREOF | IMMT, MICA, TAP1 | GLP1R 710/4885FOLH1 1511/4885CCKAR 1112/4885 |
| US-10398782-B2 | MIC-1 compounds and uses thereof | IMMT, MICA, TAP1 | GLP1R 710/4885FOLH1 1511/4885CCKAR 1112/4885 |
| US-20230364248-A1 | MIC-1 COMPOUNDS AND USES THEREOF | IMMT, MICA, TAP1 | GLP1R 710/4885FOLH1 1511/4885CCKAR 1112/4885 |
| US-20180339057-A1 | MIC-1 Compounds and Uses Thereof | IMMT, MICA, TAP1 | GLP1R 710/4885FOLH1 1511/4885CCKAR 1112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.